Overview
Human Age-related Macular Degeneration Serum for Research
Our Age-related Macular Degeneration Serum is sourced from IRB-consented donors clinically diagnosed with age-related macular degeneration (AMD). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for inflammation and ophthalmological studies.
Product Features
- Collected from clinically confirmed Age-related Macular Degeneration (AMD) donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
Donor Metadata
- AMD diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for Age-related Macular Degeneration (AMD) and ophthalmological conditions
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Age-related Macular Degeneration serum is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Protocol and Documentation
Resources and Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.